Dr Boris Adryan, Digital & Data Capability Building Lead at Merck Healthcare KGaA, teaches the company’s workforce the importance of data.

The amount of data created by pharmaceutical companies has increased exponentially over the last few decades. Managing these enormous volumes of data can be challenging, an issue compounded by a lack of standardisation. Data is often gathered from numerous sources and devices and stored separately, making it difficult to retrieve, query, share and analyse. 

This September, our PharmaTec series discussion group focused on cutting edge data analytics. Some of the key topics our experts covered included whether analytics should start with the data or a use case first, different analytical platforms and the application of AI/ML technologies.  

Leading up to our mobile robotics congress, we have the pleasure of speaking with Daniel Leidner, Research Group Leader, DLR German Aerospace Center, where we explore his views on Space Robotics to Mobile Lab Robotics of the Future

Workshop featuring presentations by: Ranjeet Patil, Senior Director, Head of Innovation Management for BioContiuum™ Platform | Aniruddha Bose, Bioprocess Automation Consultant, Merck KGaA, Darmstadt, Germany | Hemant Garg, Bio4C™ ProcessPad Product Manager | Kévin Grollier, PAT Implementation and Support Engineer | Lukasz Paciorkowski, Digital Practitioner | Nishant Gupta, Associate Director – BioContinuum™ Platform | Philippe Eberhard, IT Architect at Merck KGaA, Darmstadt, Germany | Sujatha Gopi, Software Regulatory Subject Matter Expert | René Reinbigler, Head of Digital Technologies

The foundation of any 21st century smart lab is data management and connectivity.

How can pharma companies harness the power of data using innovative technologies?

In Conversation With...Clive Higgins, Head of Connected Lab, Merck

Bringing you the latest news from Oxford Global’s Pharma I.T. and Data, A.I. in Drug Development and SmartLabs Laboratory Informatics congresses

What is being done to overcome difficulties with supply chains, regulatory processes, and scalability?